1. Prediction of lithium response in first-episode mania using the LITHium Intelligent Agent (LITHIA): Pilot data and proof-of-concept.
- Author
-
Fleck DE, Ernest N, Adler CM, Cohen K, Eliassen JC, Norris M, Komoroski RA, Chu WJ, Welge JA, Blom TJ, DelBello MP, and Strakowski SM
- Subjects
- Adolescent, Adult, Antimanic Agents administration & dosage, Antimanic Agents adverse effects, Artificial Intelligence, Diagnostic and Statistical Manual of Mental Disorders, Drug Monitoring methods, Female, Fuzzy Logic, Humans, Male, Multimodal Imaging methods, Pilot Projects, Predictive Value of Tests, Prognosis, Behavioral Symptoms diagnosis, Behavioral Symptoms drug therapy, Bipolar Disorder diagnosis, Bipolar Disorder drug therapy, Bipolar Disorder psychology, Drug Resistance, Lithium Compounds administration & dosage, Lithium Compounds adverse effects, Magnetic Resonance Imaging methods, Proton Magnetic Resonance Spectroscopy methods
- Abstract
Objectives: Individualized treatment for bipolar disorder based on neuroimaging treatment targets remains elusive. To address this shortcoming, we developed a linguistic machine learning system based on a cascading genetic fuzzy tree (GFT) design called the LITHium Intelligent Agent (LITHIA). Using multiple objectively defined functional magnetic resonance imaging (fMRI) and proton magnetic resonance spectroscopy (
1 H-MRS) inputs, we tested whether LITHIA could accurately predict the lithium response in participants with first-episode bipolar mania., Methods: We identified 20 subjects with first-episode bipolar mania who received an adequate trial of lithium over 8 weeks and both fMRI and1 H-MRS scans at baseline pre-treatment. We trained LITHIA using 181 H-MRS and 90 fMRI inputs over four training runs to classify treatment response and predict symptom reductions. Each training run contained a randomly selected 80% of the total sample and was followed by a 20% validation run. Over a different randomly selected distribution of the sample, we then compared LITHIA to eight common classification methods., Results: LITHIA demonstrated nearly perfect classification accuracy and was able to predict post-treatment symptom reductions at 8 weeks with at least 88% accuracy in training and 80% accuracy in validation. Moreover, LITHIA exceeded the predictive capacity of the eight comparator methods and showed little tendency towards overfitting., Conclusions: The results provided proof-of-concept that a novel GFT is capable of providing control to a multidimensional bioinformatics problem-namely, prediction of the lithium response-in a pilot data set. Future work on this, and similar machine learning systems, could help assign psychiatric treatments more efficiently, thereby optimizing outcomes and limiting unnecessary treatment., (© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)- Published
- 2017
- Full Text
- View/download PDF